Amid continuing concerns that anthrax might be used as a bioterrorism weapon, government researchers report development of a faster, more sensitive blood test for detecting the deadly toxins produced by the anthrax bacterium, Bacillus anthracis. The test produces results in only 4 hours and could save lives by allowing earlier detection of infection, they say.
Their study is scheduled for publication in the Nov. 22 issue of ACS’ Analytical Chemistry, a semi-monthly journal.
Standard identification of anthrax (Bacillus anthracis) infection relies on a combination of time-consuming steps, including cell culture and gene amplification, which can take several days to provide a diagnosis and have limitations for detecting early stages of infection. Early diagnosis is critical for effective treatment of pulmonary or inhalation anthrax, the most deadly form.
John R. Barr and colleagues in a multi-center team effort used a form of mass spectrometry to detect the presence of ‘lethal factor,’ the key toxin produced by the anthrax bug, in the blood of monkeys with inhalation anthrax. The method took only four hours to identify the toxin and detected it at very low levels, demonstrating its potential for early detection of infection, the researchers say.
The new method also shows promise as a research tool for providing a better understanding of the anthrax infection cycle and for evaluating the effectiveness of different therapies and methods to fight infections.
Source: ACS
Related stories:
Magnetic nanoparticles detect and remove harmful bacteria
Researchers in Ohio report the development of magnetic nanoparticles that show promise for quickly detecting and eliminating E. coli, anthrax, and other harmful bacteria. In laboratory studies, the nanoparticles helped detect a strain of E. coli within five minutes and removed 88 percent of the target bacteria, the scientists say. Their study is scheduled for the Nov. 7 issue of the
Journal of the American Chemical Society.
Anthrax paralyzes immune cells with lethal toxin
University of Florida researchers have revealed how the inhaled form of anthrax paralyzes the body’s defenses and prevents immune cells from reaching the site of infection.
US 'confident' dead scientist behind anthrax attacks
US authorities are "confident" that a government scientist who killed himself last month was the only person responsible for deadly anthrax attacks in the United States in 2001, officials said Wednesday.
Francisella tularensis: Stopping a biological weapon
Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen
Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently we knew very little about this bacterium. However, according to the August issue of the
Journal of Medical Microbiology, research on the bacterium has been reinvigorated and rapid progress has been made in understanding how it causes disease.
China seals off quake town over epidemic fears: report
One of the towns worst hit in last month's devastating China earthquake has been sealed off to prevent epidemics from spreading, after having been opened just briefly, state media said Saturday.
Avalanche photodiodes target bioterrorism agents
Researchers have shown that a new class of ultraviolet photodiode could help meet the U.S. military's pressing requirement for compact, reliable and cost-effective sensors to detect anthrax and other bioterrorism agents in the air.
Detection instrument can sniff out airborne terrorist threats
Security and law enforcement officials may some day have a new ally - a universal detection system that can monitor the air for virtually all of the major threat agents that could be used by terrorists.
Biochips can detect cancers before symptoms develop
In their fight against cancer, doctors have just gained an impressive new weapon to add to their arsenal. Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a chip that can save lives by diagnosing certain cancers even before patients become symptomatic.
